References
- Thomas R, Francis R, Davies HE, Lee YC. (2014). Interventional therapies for malignant pleural effusions: the present and the future. Respirology 19:809–22.
- Goldstraw P, Chansky K, Crowley J, et al. (2016). The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39–51.
- Antunes G, Neville E. (2000). Management of malignant pleural effusions. Thorax 55:981–3.
- Tattersall M. (1998). Management of malignant pleural effusion. Aust N Z J Med 28:394–6.
- Tan G, Chia C, Kumar M, et al. (2017). 201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre. Int J Hyperthermia 33:288–94.
- Isik AF, Sanli M, Yilmaz M, et al. (2013). Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies. Respir Med 107:762–7.
- Ba M, Long H, Wang Y, et al. (2013). Intrapleural hyperthermic perfusion using distilled water at 48 degrees C for malignant pleural effusion. J Cancer Res Clin Oncol 139:2005–12.
- Yildirim H, Metintas M, Ak G, et al. (2008). Predictors of talc pleurodesis outcome in patients with malignant pleural effusions. Lung Cancer 62:139–44.
- Beheshtirouy S, Kakaei F, Mirzaaghazadeh M. (2013). Video assisted rigid thoracoscopy in the diagnosis of unexplained exudative pleural effusion. J Cardiovasc Thorac Res 5:87–90.
- Boutin C, Viallat JR, Cargnino P, Farisse P. (1981). Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 124:588–92.
- Yildirim E, Dural K, Yazkan R, et al. (2005). Rapid pleurodesis in symptomatic malignant pleural effusion. Eur J Cardiothorac Surg 27:19–22.
- Davies HE, Lee YC. (2013). Management of malignant pleural effusions: questions that need answers. Curr Opin Pulm Med 19:374–9.
- Maskell NA, Lee YC, Gleeson FV, et al. (2004). Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 170:377–82.
- Azzopardi M, Porcel JM, Koegelenberg CF, et al. (2014). Current controversies in the management of malignant pleural effusions. Semin Respir Crit Care Med 35:723–31.
- Roberts ME, Neville E, Berrisford RG, et al. (2010). Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65:ii32–40.
- Simoff MJ, Lally B, Slade MG, et al. (2013). Symptom management in patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e455S–97S.
- Tremblay A, Mason C, Michaud G. (2007). Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 30:759–62.
- Fysh ET, Tremblay A, Feller-Kopman D, et al. (2013). Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest 144:1597–602.
- Thomas R, Budgeon CA, Kuok YJ, et al. (2014). Catheter tract metastasis associated with indwelling pleural catheters. Chest 146:557–62.
- Issels R, Kampmann E, Kanaar R, Lindner LH. (2016). Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application. Int J Hyperthermia 32:89–95.
- Wust P, Hildebrandt B, Sreenivasa G, et al. (2002). Hyperthermia in combined treatment of cancer. Lancet Oncol 3:487–97.
- Saga T, Sakahara H, Nakamoto Y, et al. (2001). Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia. Eur J Cancer 37:1429–34.
- Han SI, Duong HQ, Choi JE, et al. (2008). Hyperthermia switches glucose depletion-induced necrosis to apoptosis in A549 lung adenocarcinoma cells. Int J Oncol 32:851–60.
- Luchetti F, Mannello F, Canonico B, et al. (2004). Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia-related apoptosis. Apoptosis 9:635–48.
- Kong G, Anyarambhatla G, Petros WP, et al. (2000). Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 60:6950–7.
- Kodama K, Doi O, Tatsuta M, et al. (1989). Development of postoperative intrathoracic chemo-thermotherapy for lung cancer with objective of improving local cure. Cancer 64:1422–8.
- Shigemura N, Akashi A, Nakagiri T, et al. (2004). Pleural perfusion thermo-chemotherapy under VATS: a new less invasive modality for advanced lung cancer with pleural spread. Ann Thorac Surg 77:1016–21.
- Migliore M, Calvo D, Criscione A, et al. (2015). Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience. Future Oncol 11:47–52.